Japan Non-Small Cell Lung Cancer Diagnostics Market (2025-2031) | Industry, Share, Trends, Segmentation, Value, Forecast, Companies, Growth, Size & Revenue, Analysis, Outlook, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Japan Country Macro Economic Indicators

3.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 Japan Non-Small Cell Lung Cancer Diagnostics Market - Industry Life Cycle

3.4 Japan Non-Small Cell Lung Cancer Diagnostics Market - Porter's Five Forces

3.5 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.6 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.7 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By Test, 2021 & 2031F

3.8 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume Share, By End-User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-small cell lung cancer in Japan

4.2.2 Technological advancements in diagnostic techniques

4.2.3 Rising adoption of personalized medicine approaches in cancer treatment

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for approval of diagnostic tests

4.3.2 High cost associated with advanced diagnostic technologies

4.3.3 Limited accessibility to healthcare facilities in certain regions of Japan

6.1 Japan Non-Small Cell Lung Cancer Diagnostics Market, By Cancer Type

6.1.1 Overview and Analysis

6.1.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Cancer Type, 2021- 2031F

6.1.3 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Adenocarcinoma (LUAD), 2021- 2031F

6.1.4 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Lung Squamous Cell carcinoma (LUSC), 2021- 2031F

6.1.5 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Large Cell Carcinoma, 2021- 2031F

6.1.6 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 Japan Non-Small Cell Lung Cancer Diagnostics Market, By Product

6.2.1 Overview and Analysis

6.2.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F

6.2.3 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Instruments And Services & Softwares, 2021- 2031F

6.3 Japan Non-Small Cell Lung Cancer Diagnostics Market, By Test

6.3.1 Overview and Analysis

6.3.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Imaging Test, 2021- 2031F

6.3.3 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Molecular Test, 2021- 2031F

6.3.4 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Biopsy, 2021- 2031F

6.3.5 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Sputum Cytology, 2021- 2031F

6.3.6 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Thoracentesis, 2021- 2031F

6.3.7 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F

6.4 Japan Non-Small Cell Lung Cancer Diagnostics Market, By End-User

6.4.1 Overview and Analysis

6.4.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Hospital, 2021- 2031F

6.4.3 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F

6.4.4 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Academics, 2021- 2031F

6.4.5 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

7.1 Japan Non-Small Cell Lung Cancer Diagnostics Market Export to Major Countries

7.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Imports from Major Countries

8.1 Average turnaround time for diagnostic test results

8.2 Adoption rate of novel diagnostic technologies in non-small cell lung cancer diagnosis

8.3 Patient survival rates following early diagnosis and treatment

8.4 Rate of integration of molecular profiling in diagnostic practices

8.5 Number of research collaborations between diagnostic companies and healthcare institutions

9.1 Japan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

9.3 Japan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By Test, 2021 & 2031F

9.4 Japan Non-Small Cell Lung Cancer Diagnostics Market Opportunity Assessment, By End-User, 2021 & 2031F

10.1 Japan Non-Small Cell Lung Cancer Diagnostics Market Revenue Share, By Companies, 2024

10.2 Japan Non-Small Cell Lung Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters